Emerging strategies on functionalized AT1 receptor-targeted nanoparticles such as liposomes, quantum dots, PLGA microcapsules as drug delivery systems present a creative and modern outlook on heart failure treatment [8,16,19]. This evidence concerns the gene AGTR1 and heart failure.